Dr Reddy’s initiates process for EUA of Sputnik V
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gamaleya National Research Institute
Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V…
This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study
RDIF and Dr Reddy’s to partner for trials and supply of 100 mn Sputnik V vaccine doses to India
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by…